News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NovImmune SA Strengthens Board and Management Team


7/10/2012 10:17:31 AM

GENEVA--(BUSINESS WIRE)--NovImmune SA announced the addition of Michael Steinmetz, Ph.D. to its Board of Directors and David Slack as Head of Corporate & Business Development

Dr. Steinmetz brings over 25 years of industry and investment experience within the healthcare sector. Since its inception in 2005, he has served as Managing Director of Clarus Ventures, a US$1.2 billion biotechnology investment fund based in the Boston area.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES